COMMUNIQUÉS West-GlobeNewswire

Chapin Aesthetics Begins Offering Microneedling and PRP for the Philadelphia Area
14/05/2019
2019 marks the debut of a skin-revitalizing treatment offered by Dr. Scott D. Chapin and his team DOYELSTOWN, Pa., May 14, 2019 (GLOBE NEWSWIRE) -- As a plastic surgeon in the Philadelphia area , Dr. Scott D. Chapin has [...]
During Skin Cancer Awareness Month, Dermatologists Share 5 Common Sunscreen Mistakes — and How to Avoid Them; American Academy of Dermatology
14/05/2019
ROSEMONT, Ill., May 14, 2019 (GLOBE NEWSWIRE) -- Skin cancer is the most common cancer in the United States, affecting one in five Americans in their lifetime. Yet according to dermatologists from the American Academy [...]
Tauriga Sciences Inc. to Commence Initial Production Run of Blood Orange Flavored Version of Tauri-Gum
14/05/2019
New York, NY, May 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and [...]
UK Annual Report and Notice of AGM
14/05/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Publication of UK Annual Report and Notice of Annual General Meeting Oxford, UK, and Cambridge, MA, US, 14 May 2019 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT [...]
Amedisys to Present at the 2019 RBC Capital Markets Healthcare Conference
14/05/2019
BATON ROUGE, La., May 14, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief [...]
Bavarian Nordic to Host First Quarter 2019 Results Conference Call
14/05/2019
COPENHAGEN, Denmark – May 14, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) will announce its 2019 first quarter results on Wednesday, May 22, 2019. The management of Bavarian Nordic will host a conference call at [...]
Kalytera Therapeutics, Inc. Announces Second Closing of Public Offering
14/05/2019
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. SAN FRANCISCO and TEL AVIV, [...]
Respected Neurosurgeon Brings Distinguished Career and Medical Expertise to Geocann’s Executive Management Team
14/05/2019
Anthony Petraglia, M.D., joins Geocann as Chief Medical Officer to focus on the advancement of new product innovations that target the most pressing consumer health concerns as well as the research and publication of [...]
Colibri Heart Valve to Present One-Year Patient Follow-Up Results from Clinical Feasibility Study of Second-Generation TAVI System at EuroPCR
14/05/2019
BROOMFIELD, CO , May 14, 2019 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC , a privately held emerging medical device company, today announced that results from the company’s international, single-arm, open-label early [...]
Y-mAbs Announces Development Update on Cancer Vaccine Program
14/05/2019
NEW YORK, May 14, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, [...]
CURE Pharmaceutical (OTCQB:CURR) Closes Acquisition Of Privately-Held Chemistry Holdings Inc.
14/05/2019
Acquired Technology Expands Core CUREfilmTM Platform and Strengthens Balance Sheet OXNARD, Calif., May 14, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development [...]
Oxford Immunotec to Present at the UBS Global Healthcare Conference
14/05/2019
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 14, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that Dr. Peter [...]
JSC “Grindeks” Group could reach 300 million euro turnover within five years
14/05/2019
According to the interview with Chairman of the Council of JSC “Grindeks” Kirovs Lipmans, published by National information agency LETA on 14 May 2019, JSC “Grindeks” confirms that in five years JSC “Grindeks” could [...]
Sienna Biopharmaceuticals Announces SNA-120 (0.05%) Biopsy Data Demonstrate Positive Impact on Key Inflammatory Cytokines, including IL-23 and IL-17, in Psoriasis
14/05/2019
-- Biopsy data support strong clinical effect observed in Phase 2 trials with SNA-120 -- Following Positive End-of-Phase 2 meeting with FDA, Sienna continues toward enrolling first patient in Phase 3 program in second [...]
Ventura Cannabis (VCAN) Executes LOI to Divest Corona Detox Center for $1.4M in Cash; VCAN to Retain 10-year Rights to Exclusively Supply All Cannabis Products for Opioid Treatment to Detox Center’s Patients
14/05/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ALL FIGURES IN CANADIAN DOLLARS UNLESS OTHERWISE SPECIFIED. LOS ANGELES, May 14, 2019 (GLOBE NEWSWIRE) -- Ventura [...]
Turning Point Therapeutics Names Biotech Veteran Patrick Machado, J.D. to Its Board of Directors
14/05/2019
SAN DIEGO, May 14, 2019 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel drugs to address treatment resistance, today announced the appointment of [...]
AXIM® Biotechnologies to Present at Cannastocks 2019 Q1 Conference
14/05/2019
NEW YORK, May 14, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech”, “Axim”, or the “Company”), a world leader in cannabinoid research and development, today announced that the Company [...]
Cerner to Work With DrFirst to Connect to State Prescription Drug Monitoring Programs
14/05/2019
KANSAS CITY, Mo., May 14, 2019 (GLOBE NEWSWIRE) -- Cerner (Nasdaq: CERN), a global health platform and innovation company, and DrFirst, a leading provider of medication management and data solutions, are working [...]
Adamis Pharmaceuticals Announces Conditional Acceptance by FDA of Proprietary Name for Higher Dose Naloxone Product
14/05/2019
SAN DIEGO, May 14, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today conditional acceptance by the U.S. Food and Drug Administration (FDA) of the proposed brand name for the [...]

Pages